1. Home
  2. KALA vs BOSC Comparison

KALA vs BOSC Comparison

Compare KALA & BOSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • BOSC
  • Stock Information
  • Founded
  • KALA 2009
  • BOSC 1990
  • Country
  • KALA United States
  • BOSC Israel
  • Employees
  • KALA N/A
  • BOSC N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • BOSC Computer Communications Equipment
  • Sector
  • KALA Health Care
  • BOSC Telecommunications
  • Exchange
  • KALA Nasdaq
  • BOSC Nasdaq
  • Market Cap
  • KALA 26.2M
  • BOSC 28.4M
  • IPO Year
  • KALA 2017
  • BOSC 1996
  • Fundamental
  • Price
  • KALA $6.08
  • BOSC $5.11
  • Analyst Decision
  • KALA Strong Buy
  • BOSC
  • Analyst Count
  • KALA 3
  • BOSC 0
  • Target Price
  • KALA $14.00
  • BOSC N/A
  • AVG Volume (30 Days)
  • KALA 133.6K
  • BOSC 126.0K
  • Earning Date
  • KALA 08-05-2025
  • BOSC 08-21-2025
  • Dividend Yield
  • KALA N/A
  • BOSC N/A
  • EPS Growth
  • KALA N/A
  • BOSC 35.10
  • EPS
  • KALA N/A
  • BOSC 0.49
  • Revenue
  • KALA N/A
  • BOSC $43,688,000.00
  • Revenue This Year
  • KALA N/A
  • BOSC N/A
  • Revenue Next Year
  • KALA N/A
  • BOSC N/A
  • P/E Ratio
  • KALA N/A
  • BOSC $10.11
  • Revenue Growth
  • KALA N/A
  • BOSC 0.84
  • 52 Week Low
  • KALA $2.92
  • BOSC $2.50
  • 52 Week High
  • KALA $11.20
  • BOSC $5.50
  • Technical
  • Relative Strength Index (RSI)
  • KALA 58.29
  • BOSC 55.59
  • Support Level
  • KALA $5.39
  • BOSC $4.85
  • Resistance Level
  • KALA $7.00
  • BOSC $5.10
  • Average True Range (ATR)
  • KALA 0.71
  • BOSC 0.20
  • MACD
  • KALA 0.04
  • BOSC -0.04
  • Stochastic Oscillator
  • KALA 51.89
  • BOSC 50.00

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

Share on Social Networks: